CD4 and plasma cell myeloma: The balance between anti-tumor activity by cytotoxic CD8+ T cells and immunosuppression by CD4+ Treg cells is considered a key driver of progression in myeloma from the preliminary monoclonal gammopathy of undetermined significance (MGUS) to MM by many reports [270].